PharmaZell GmbH - Strategic SWOT Analysis Review

PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description - A detailed description of the company’s operations and business divisions.
• Corporate strategy - The publisher's summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

PharmaZell GmbH (PharmaZell), a subsidiary of Bridgepoint Advisers Ltd develops and produces generic active pharmaceutical ingredients (API) and intermediates. The company also offers formulation development services. Its major products include generic APIs and amino acids. It provides a wide range of API-related services for diverse phases of the drug development process for producers of generic drugs and for originators in the pharmaceutical industry. The development services range from evaluation to registration includes project management, finished dosage form, process R&D, analytical R&D, pilot scale manufacturing API, pilot scale manufacturing FDF and regulatory documentation. The company has manufacturing facilities in Raubling, Germany; Gropello, Italy; and Chennai and Vizag, India. PharmaZell is headquartered in Raubling, Germany.

PharmaZell GmbH Key Recent Developments

• Jan 27, 2022: PharmaZell Group will be attending CPHI 2021 - make appointments to visit us in Milano at booth 18J10
• Sep 16, 2021: PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
• Jul 27, 2021: Pharma Zell(India) Private awarded EcoVadis Silver Medal in recognition for Sustainability Performance

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.